🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate safety, tolerability, pharmacokinetics, pharmacodynamics and...
Status
Completed
Location
Fukuoka Clinical Site
Start Date
2019-09-12
Trial ID
NCT04079062
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
This is a Phase 1, randomized, double-blind, placebo-controlled, first-in-h...
Status
Completed
Location
HLB Science
Start Date
2023-07-24
Trial ID
NCT07347223
The main purpose of this study is to evaluate safety, tolerability, pharmac...
Status
Completed
Location
Nuvisan GmbH
Start Date
2021-08-03
Trial ID
NCT05018403
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Quotient Clinical
Start Date
2013-08
Trial ID
NCT01918735
The purpose of this study is to evaluate the safety, tolerability, drug lev...
Status
Terminated
Location
Medvin Clinical Research - Metyas
Start Date
2021-02-16
Trial ID
NCT04684654
Treatments Being Tested
This is a Phase I, multi-center, double-blind, randomized, placebo-controll...
Status
Completed
Location
Acorda Investigational Site
Start Date
2013-03
Trial ID
NCT01803867
Treatments Being Tested
To evaluate the safety,tolerability and pharmacokinetics of single-multiple...
Status
Completed
Location
Huashan Hospital affiliated to Fudan University
Start Date
2020-07-05
Trial ID
NCT05055687
The current study is the second clinical administration with PF-07304814, t...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2020-10-23
Trial ID
NCT04627532
Treatments Being Tested
This study is designed to measure the effects of LGT209 when given intraven...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-12
Trial ID
NCT01979601